2nd Quarter - Report

FORWARD GLOBAL for QUOIN PHARMACEUTICALS, INC.

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Advocating for robust support of the rare disease community at large, including continued government funding for rare disease research and development, clinical trial reform to accelerate the path to new treatments, and financial incentives such as the Rare Pediatric Disease Designation and Priority Review Voucher Programs that encourage investment in this space.

LobbyistCovered position, as disclosed
LEAH CHARETTE —
AVA COFIELL —
NOE GARCIA —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.